Gedeon Richter outlines clinical guidelines for Escapelle emergency contraceptive

Gedeon Richter’s Escapelle tablets, formulated with the active ingredient levonorgestrel, are indicated for emergency contraception to prevent pregnancy following contraceptive failure or unprotected sexual activity. The drug acts primarily by delaying or inhibiting ovulation through hormonal influence on the menstrual cycle.

Clinical guidelines specify that the medication must be administered within a 72-hour window following an incident. Data indicates that efficacy is higher when the treatment is taken within the first 12 hours. Gedeon Richter emphasizes that this is an emergency method and should not be used as a routine contraceptive substitute, nor is it effective once pregnancy has been established.

Potential users are advised against taking the drug if they suffer from severe liver conditions or have a known pregnancy. Furthermore, the company notes that if menstrual bleeding is delayed by more than five days, a pregnancy test is required, as there remains a risk of ectopic pregnancy in rare cases where the emergency contraception fails.